Science, Technology and Information Minister Khairy Jamaluddin today assured that a programme to vaccinate workers from the manufacturing and related services sectors on a large scale will only be rolled out once there is enough vaccine supply for the general public in Phase Three of the national immunisation programme.
In a series of Twitter posts, he added that no move towards this would be made when vaccines are in short supply.
“The reason this programme exists is for PICK to offer vaccinations at big industrial sites/factories,” he said, using the acronym for the National Covid-19 Immunisation Programme.
“This will prevent factory workers from having to come to PPVs and for vaccinations to be done in situ. This will only commence when there are enough vaccines for Phase Three.”
He was referring to the Public Private Partnership Immunisation Model or on-site vaccination under the Covid-19 Vaccination Programme for Manufacturing and Related Services, a statement on which had been issued by the Federation of Malaysian Manufacturers (FMM) on April 27.
FMM had said that the model would require a minimum threshold of 1,500 employees including contractors or vendors who work on-site and who have already registered for vaccination through MySejahtera.
It said registration to express interest in participating would begin on May 1.
In his Twitter posts, Khairy who is in charge of PICK, said this programme had yet to begin.
“If you look closely, this is just for expressions of interest,” he added.
He said the programme for workers would be rolled out through a public-private partnership in which factories would pay for the cost of setting up vaccination sites while the government provides vaccines for free from PICK.
“Again, (this) starts when (there is) enough supply for Phase Three,” he said.
According to the FMM statement, the Covid-19 Immunisation Task Force for manufacturing and related services comprising the international trade and industry ministry, the health ministry and Khairy’s science, technology and information ministry will assess each application before deciding on the next course of action.
FMM also said the only vaccine currently available for this model is China’s Sinovac jab.